DNAM1/CD226 is a potent activating receptor that has been shown to recognize two ligands overexpressed by tumor cells [82], namely PVR/CD155 which is considered as the main ligand [83] and Nectin2/CD112 [84]. The gene discussed is CD226; the disease is neoplasm.